Skip to main content

Table 5 Survival rate in incident patients with ESKD, censored at transplantation (mean percentage and 95% confidence interval [CI])

From: Incidence and survival of end-stage kidney disease due to polycystic kidney disease in Australia and New Zealand (1963–2014)

PKD 0.5 years 1 year 3 years 5 years
 1963–1974 96.2 [90.9–98.4] 90.9 [82.7–95.4] 73.7 [59.3–83.7] 51.3 [34.2–66.0]
 1975–1984 98.5 [97.0–99.3] 94.8 [92.2–96.6] 80.8 [75.6–85.0] 62.5 [55.3–68.8]
 1985–1994 96.9 [95.5–97.9] 94.0 [92.1–95.5] 79.9 [76.4–82.9] 59.9 [55.0–64.3]
 1995–2004 98.3 [97.4–98.9] 95.9 [94.5–96.9] 83.1 [80.5–85.3] 69.4 [66.1–72.5]
 2005–2014 98.3 [97.6–98.9] 96.6 [95.5–97.4] 87.6 [85.4–89.5] 77.7 [74.4–80.6]
Non-PKD
 Total
  1963–1974 92.7 [91.4–93.8] 87.1 [85.1–88.8] 66.9 [62.9–70.6] 55.1 [50.1–59.8]
  1975–1984 93.8 [93.1–94.4] 87.1 [86.1–88.1] 64.6 [62.9–66.2] 45.9 [43.9–47.9]
  1985–1994 94.5 [94.1–95.0] 88.7 [87.9–89.2] 61.9 [60.8–63.0] 40.2 [39.0–41.4]
  1995–2004 93.6 [93.3–94.0] 87.0 [86.5–87.5] 62.7 [62.0–63.4] 42.9 [42.1–43.7]
  2005–2014 93.7 [93.4–94.0] 88.5 [88.1–88.9] 67.3 [66.6–67.9] 48.5 [47.7–49.3]
 Diabetic/Vascular
  1963–1974 83.6 [76.8–88.5] 77.7 [69.7–83.8] 55.6 [42.5–66.8] 51.9 [37.8–64.3]
  1975–1984 88.7 [86.1–90.8] 78.1 [74.7–81.0] 47.6 [43.1–52.0] 25.3 [21.0–29.8]
  1985–1994 92.0 [90.9–93.0] 83.5 [82.0–84.9] 48.4 [46.4–50.5] 24.9 [23.1–26.8]
  1995–2004 92.7 [92.1–0.93.2] 84.8 [84.1–85.6] 56.2 [55.1–57.3] 34.1 [33.0–35.2]
  2005–2014 93.9 [93.5–94.3] 88.2 [87.6–88.7] 64.2 [63.3–65.0] 43.5 [42.4–44.5]
 Non-vascular
  1963–1974 93.6 [92.2–94.7] 88.0 [86.0–89.8] 68.0 [63.8–71.9] 55.6 [50.3–60.6]
  1975–1984 94.6 [93.9–95.3] 88.6 [87.6–89.69] 67.6 [65.8–69.3] 49.8 [47.6–52.0]
  1985–1994 95.5 [95.0–95.9] 90.4 [89.7–91.1] 67.7 [66.4–68.9] 47.3 [45.8–48.8]
  1995–2004 94.4 [93.9–94.8] 88.7 [88.1–89.3] 68.3 [67.3–69.3] 51.1 [50.0–52.2]
  2005–2014 93.5 [93.1–94.0] 89.0 [88.4–89.6] 71.5 [70.5–72.4] 55.7 [54.4–56.9]
  1. Note: Non-PKD group shown as “Total” or sub-divided into “Vascular/Diabetes” and “Non-vascular”